Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.4500
0.00 (0.00%)
Jul 28, 2026, 4:00 PM EDT - Market closed
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $15.04 million as of July 29, 2026. Its market cap has increased by 178.25% in one year.
Market Cap
15.04M
Enterprise Value
-35.36M
1-Year Change
178.25%
Ranking
Category
Stock Price
$0.45
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $15.04M, a decrease of -76.97%. That is a compound annual growth rate of -26.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 15.04M | -49.52% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 17.10M |
| OSR Health | 16.03M |
| Moolec Science | 15.11M |
| Cyclerion Therapeutics | 14.84M |
| Akari Therapeutics, | 14.76M |
| Passage Bio | 14.66M |
| Vyome Holdings | 13.97M |
| SeaStar Medical Holding | 13.83M |